Clinical Trials
28 trialsNCT06313801 2025-11-21
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
Nizhny Novgorod Regional Clinical Oncology Center
Phase 2 Recruiting
NCT05177068 2025-10-02
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT02078700 2025-06-25
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT06942663 2025-04-24
JAGC1
Nizhny Novgorod Regional Clinical Oncology Center
Phase 2 Not yet recruiting
NCT03950271 2024-02-28
SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
NCT06197438 2024-01-09
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05751265 2023-06-22
Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT04519151 2023-06-08
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Phase 2 Recruiting
NCT05750290 2023-03-01
CKD-702 Plus Irinotecan in Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT04893252 2022-11-30
Vactosertib and Durvalumab in Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT03939962 2022-01-26
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT02845908 2021-04-23
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Completed
NCT04155671 2019-11-07
POF Versus FOLFOX Plus IP Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Unknown
NCT04149015 2019-11-04
Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT03837301 2019-02-12
Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)
National Cancer Center, Korea
Phase 2 Unknown
NCT02697838 2018-10-17
Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT02572050 2016-04-20
AaRon
National Cancer Center, Korea
Phase 2 Unknown
NCT01088204 2015-10-07
COACT_1001
National Cancer Center, Korea
Phase 2 Unknown
NCT01331928 2011-04-08
Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer
Taipei Veterans General Hospital, Taiwan
Phase 2 Unknown
NCT01163812 2010-07-19
NCC181
National Cancer Center, Korea
Phase 2 Completed
NCT00948337 2010-02-26
A Study With Health Educational Material on Health Promotion in Cancer Survivors
National Cancer Center, Korea
Phase 2 Unknown
NCT01002443 2009-10-27
Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer
National Cancer Center, Korea
Phase 2 Completed
NCT00980603 2009-09-21
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00512681 2009-09-18
TIROX2
National Cancer Center, Korea
Phase 2 Completed
NCT00580359 2008-01-08
S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00515190 2008-01-07
Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
National Cancer Center, Korea
Phase 2 Unknown
NCT00587145 2008-01-07
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown